Biomedical Engineering Reference
In-Depth Information
Pinkerton K, Pleus RC, Shatkin JA, Thomas R, Tolaymat T, Wang A. (2013a) A multi-
stakeholder perspective on the use of alternative test strategies for nanomaterial safety
assessment.
ACS Nano
: 7:6422-6433.
Nel AE, Xia T, Meng H, Wang X, Lin S, Ji Z, Zhang H. (2013b). Nanomaterial toxicity test-
ing in the 21st century: Use of a predictive toxicological approach and high-throughput
screening.
Acc Chem Res
46:607-621.
Oberdörster G. (2009) Safety assessment for nanotechnology and nanomedicine: Concepts of
nanotoxicology.
J Int Med
267:89-105.
OECD. (2007). Guidance on grouping of chemicals. Series on testing and assessment No. 80.
ENV/JM/MONO(2007)28. OECD, Paris, France, 26 September 2007.
OECD. (2010). Guidance manual for the testing of manufactured nanomaterials: OECD's
sponsorship programme; first revision. ENV/JM-MONO(2009)20/REV, OECD, Paris,
France, 2 June 2010.
OECD. (2011). A steering group 7 case-study for hazard identification of inhaled nanomaterials:
An integrated approach with short-term inhalation studies. ENV/CHEM/NANO(2011)6/
REV1. 10th Meeting of the Working Party on Manufactured Nanomaterials, OECD,
Paris, France, 27-29 June 2012.
OECD. (2012a). Proposal for a template, and guidance on developing and assessing the com-
pleteness of adverse outcome pathways. 17 pp; available at: http://www.oecd.org/env/
ehs/testing/49963554.pdf.
OECD. (2012b). Appendix I. Collection of working definitions. OECD, Paris, France; avail-
able at: http://www.oecd.org/env/ehs/testing/49963576.pdf.
OECD. (2013). Revised Draft Recommendation of the Council on the safety testing and assess-
ment of manufactured nanomaterials. ENV/CHEM/NANO(2013)3/REV1 Working
Party on Manufactured Nanomaterials. OECD, Paris, France, 25 February 2013.
Oomen AG, Bos PMJ, Fernandes TF, Hund-Rinke K, Boraschi D, Byrne HJ, Aschberger K,
Gottardo S, van der Kammer F, Kühnel D, Hristozov D, Marcomini A, Migliore L, Scott-
Fordsmand J, Wick P, Landsiedel R. (2013). Concern-driven integrated approaches to
nanomaterial testing and assessment - Report of the NanoSafety Cluster Working Group
10.
Nanotoxicol
28 May 2013, epub ahead of print.
Packroff R. (2013). The synergic dimensions of OSH strategy in the context of other EU poli-
cies: Nanomaterials …and other advanced materials. Presentation on behalf of the German
Federal Institute for Occupational Safety and Health. ETUI Conference: EU Strategy for
health and safety and work 2013-2020, Brussels, 27 March 2013; available at: http://www.
etui.org/Events/Conference-on-the-European-Health-and-Safety-Strategy-2013-2020.
Patlewicz G, Ball N, Booth ED, Hulzebos E, Zvinavashe E, Hennes C. (2013). Use of category
approaches, read-across and (Q)SAR: General considerations.
Regul Toxicol Pharmacol
67:1-12.
Rallo R, France B, Liu R, Nair S, George S, Damoiseaux R, Giralt F, Nel AE, Bradley
K, Cohen Y. (2011). Self-organizing map analysis of toxicity-related cell
signaling pathways for metal and metal oxide nanoparticles.
Env Science Technol
45:1695-1702.
Rehn B, Rehn S, Bruch J. (1999). Ein neues in-vitro-Prüfkonzept (Vektorenmodell) zum
biologischen Screening und Monitoring der Lungentoxizität von Stäuben.
Gefahrstoffe-
Reinhaltung der Luft
59:181-188.
Rothen-Rutishauser B, Brown DM, Piallier-Boyles M, Kinloch IA, Windle AH, Gehr P,
Stone V. (2010). Relating the physicochemical characteristics and dispersion of mul-
tiwalled carbon nanotubes in different suspension media to their oxidative reactivity in
vitro and inflammation in vivo.
Nanotoxicol
4:331-342.
Russell WMS, Burch RL. (1959). The principles of humane experimental technique. London,
UK. Methuen. Reprinted by UFAW, 1992, 238 pp., 8 Hamilton Close, South Mimms,
Potters Bar, Herts EN6 3QD England.
Search WWH ::
Custom Search